Considering the clinical implications of new research data on migraine and brain lesions
Migraine has received considerable attention in the past 15 years as it has come to be better understood as a brain disorder with new and efficient treatment strategies.1 The World Health Organization considers a day with severe migraine to be in the highest category of disability, comparable to quadriplegia.2 Migraine is classically described and defined as an episodic disturbance manifest primarily as head pain and sensitivity to afferent stimuli, such as light (photophobia), sound (phonophobia) and head movement.3 Against this background, new data have emerged that open the issue of whether migraine may be progressive in some way.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
- 2 petergATion.ucl.ac.uk
- 1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine — current understanding and treatment. N Engl J Med 2002; 346: 257-270.
- 2. Menken M, Munsat TL, Toole JF. The global burden of disease study — implications for neurology. Arch Neurol 2000; 57: 418-420.
- 3. Headache Classification Committee of the International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia 2004; 24 (Suppl 1): 1-160.
- 4. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291: 427-434.
- 5. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001; 100: 215-220.
- 6. Bousser M-G, Conard J, Kittner S, et al. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. Cephalalgia 2000; 20: 155-156.
- 7. Lipton RB, Pan J. Is migraine a progressive brain disease? JAMA 2004; 291: 493-494.
- 8. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001; 41: 646-657.
- 9. Welch KMA, Goadsby PJ. Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 2002; 15: 287-295.
- 10. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003; 106: 81-89.
- 11. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2004: doi:10.1136/bmj.38302.504063.8F [Epub ahead of print, 20 December 2004].